Telangiectasis Clinical Trial
Official title:
Evaluation of Laser Therapy Vs Electrosurgery For Nasal Telangiectasias Using A Novel Vascular Imaging Device
Verified date | June 2017 |
Source | University of California, Davis |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this study is to compare the efficacy of various treatment options for eliminating nasal telangiectasias. The study will compare the outcome of treating nasal telangiectasias with the following; no treatment (control site), alexandrite laser, pulsed dye laser, combination pulsed dye laser and Nd:YAG 1064nm multiplex laser system and electrosurgery.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | February 2016 |
Est. primary completion date | February 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Over 18 years of age - Able to give informed consent themselves - Willing to return for follow up visit - 0.5 - 3 millimeter Vessel size - 5 Non-contiguous nasal vascular lesions Exclusion Criteria: - Mentally handicapped - Unable to understand written and oral English - Incarceration - Under 18 years of age - Unwilling to return for follow up - Pregnant Women - Vessels less than 0.5 millimeter caliber - Less than 5 non-contiguous vessels |
Country | Name | City | State |
---|---|---|---|
United States | University of California-Davis, Department of Dermatology | Sacramento | California |
Lead Sponsor | Collaborator |
---|---|
University of California, Davis |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Reduction of Area of Nasal Telangiectasias by Laser Therapy Vs Electrosurgery | The study will measure the changes in length and width (area) of nasal telangiectasias before and after treatment with the following: no treatment (control site), alexandrite laser, pulsed dye laser, combination pulsed dye laser and Nd:YAG 1064nm multiplex laser system and electrosurgery. | 3 months | |
Secondary | Evaluation of Cosmetic Improvement | Percent perceived improvement for nasal vessels by the patient via questionnaire. | 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT00406380 -
Effect of Avastin in Juxtafoveal Telangiectasias
|
Phase 3 | |
Completed |
NCT00005386 -
Biobehavioral Determinants of Obesity in Black Women
|
N/A | |
Completed |
NCT00005392 -
Epidemiology of Venous Disease
|
N/A | |
Completed |
NCT01205035 -
High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia
|
Phase 2 | |
Completed |
NCT01362192 -
Treatment of Lower Extremity Spider Veins With Excel V
|
Phase 4 | |
Completed |
NCT00725244 -
Trial of Endoscopy Bipolar and Argon of Chronic Rectal Bleeding From Radiation Telangiectasias
|
Phase 4 | |
Completed |
NCT02657252 -
Polidocanol Versus Glucose Treatment of Telangiectasia Trial
|
Phase 4 | |
Completed |
NCT02104271 -
Comparison Between Two Different Parameters of Argon Plasma Coagulation in the Treatment of Chronic Radiation Proctitis: Historical Control Trial.
|
Phase 2 | |
Completed |
NCT00451763 -
Intravitreal Bevacizumab for Idiopathic Macular Telangiectasia
|
Phase 3 | |
Completed |
NCT05860439 -
Lower Limb Sclerotherapy of Reticular Veins and Telangiectasias
|
||
Recruiting |
NCT00206921 -
Pulsed Dye Laser and Intense Pulsed Light (IPL) for the Treatment of Telangiectasia and Skin Redness
|
N/A |